H1741B2713A04343 AJB:JMT 05/26/22 #90 A04343
AMENDMENTS TO HOUSE BILL NO. 1741
Sponsor: REPRESENTATIVE KEEFER
Printer's No. 2713
Amend Bill, page 2, line 5, by striking out "Occupational and
Professional" and inserting
Professional and Occupational
Amend Bill, page 2, by inserting between lines 6 and 7
"Off-label use." The use of a therapeutic drug for a
treatment other than a treatment specified in the labeling
approved by the United States Food and Drug Administration.
Amend Bill, page 2, line 17, by striking out "A" and
inserting
If a prescriber determines that the prescribing of a
therapeutic drug for off-label use is in the best interest of a
patient for the treatment of coronavirus due to the patient's
individual medical condition, the
Amend Bill, page 2, line 19, by striking out "a" where it
occurs the first time and inserting
the
Amend Bill, page 2, lines 26 through 30; page 3, lines 1
through 5; by striking out all of said lines on said pages and
inserting
(b) Screenings and exposure.--A patient shall not be
required to show a positive screening results test or have a
suspected exposure to coronavirus for a prescriber to prescribe,
and a pharmacist to dispense, a therapeutic drug for off-label
use to the patient for treatment of coronavirus infections as
authorized under subsection (a).
2022/90AJB/HB1741A04343 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25